Misplaced Pages

Citalopram: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 13:07, 3 January 2007 editAgjchs (talk | contribs)104 edits added external link← Previous edit Revision as of 14:04, 3 January 2007 edit undoJmax- (talk | contribs)910 editsm Reverted edits by Agjchs to last version by OhnoitsjamieNext edit →
Line 73: Line 73:
* *
* *
* free PDF containing comprehensive charts



Lunbeck's official websites for citalopram under the trade name Cipramil: Lunbeck's official websites for citalopram under the trade name Cipramil:

Revision as of 14:04, 3 January 2007

Pharmaceutical compound
Citalopram
Clinical data
Pregnancy
category
  • C
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • US: WARNING
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability80%
Metabolismhepatic (CYP3A4 & CYP2C19)
Elimination half-life35 hours
ExcretionMostly as unmetabolized Citalopram, partly DCT and traces of DDCT
Identifiers
IUPAC name
  • 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-
    1,3-dihydroisobenzofuran-5-carbonitrile
CAS Number
PubChem CID
DrugBank
CompTox Dashboard (EPA)
ECHA InfoCard100.056.247 Edit this at Wikidata
Chemical and physical data
FormulaC20H21FN2O
Molar mass324.392 g/mol g·mol

Citalopram is an antidepressant drug used to treat depression associated with mood disorders. It is also used on occasion in the treatment of body dysmorphic disorder and anxiety.

Citalopram belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs). It is sold under the brand-names Celexa™ (U.S., Forest Laboratories, Inc.), Cipramil™ , Seropram™ (Europe and Australia), Celepram™ and Ciazil™ (Australia).

History

Citalopram was originally created by the pharmaceutical company Lundbeck and the patent for it expired in 2003, allowing other companies legally to produce generic versions.

Lundbeck has recently released an updated formulation called escitalopram oxalate (also known as Cipralex™ or Lexapro™), which is simply the S-enantiomer of the racemic citalopram (see below), and acquired a new patent for it.

Indications

Approved

Citalopram is primarily used to treat the symptoms of depression but can also be prescribed for social anxiety disorder, panic disorder or obsessive-compulsive disorder. Also prescribed in Huntington's Disease.

Unapproved/Off-label/Investigational

Citalopram has been found to significantly reduce the symptoms of diabetic neuropathy and premature ejaculation. There is also evidence that citalopram may be effective in the treatment of post-stroke pathological crying.

Side effects and drug interactions

Citalopram is safe and well-tolerated in the therapeutic dose range of 20 to 60 mg/day. Distinct from some other agents in its class, Citalopram exhibits linear pharmacokinetics and minimal drug interaction potential, making it a better choice for the elderly or comorbid patients.

Citalopram can have a number of adverse effects. In clinical trials, over 10% of patients reported fatigue, drowsiness, dry mouth, increased sweating (hyperhidrosis), trembling, headache, dizziness, sleep disturbances, cardiac arrythmia, blood pressure, nausea/vomiting, diarrhea, heightened anorgasmia in females, impotence and ejaculatory problems. In rare cases (around over 1% of cases), some allergic reactions, convulsions, mood changes, anxiety and confusion have been reported. Another uncommon side effect is bruxism (teeth grinding). Occasionally, panic attacks, thoughts of suicide or self-harm may occur or increase in the first few weeks, before the antidepressant effect starts.

Citalopram and other SSRIs have been shown to cause sexual side effects in some patients, both males and females. Although usually reversible, these sexual side effects can sometimes last for months, years or possibly indefinitely even after the drug has been completely withdrawn. This disorder is known as Post SSRI Sexual Dysfunction.

Citalopram is contraindicated in individuals taking MAOIs. It is considered relatively safe in overdose, although fatal cases of dosages 840 mg to 1960 mg have been reported.

Stereochemistry

Citalopram has a stereocenter, to which a 4-fluorophenyl group and an N,N-dimethyl-3-aminopropyl group bind. Due to this chirality the molecule exists in (two) enantiomeric forms (mirror images). They are termed S-(+)-citalopram and R-(−)-citalopram.

S-(+)-citalopram R-(−)-citalopram
S-(+)-citalopram R-(−)-citalopram
S-(+)-citalopram R-(−)-citalopram

Citalopram is sold as a racemic mixture, consisting of 50% R-(−)-citalopram and 50% S-(+)-citalopram. Only the S-(+) enantiomer has the desired antidepressant effect. Lundbeck now markets the S-(+) enantiomer, the generic name of which is escitalopram. Whereas citalopram is supplied as the hydrobromide, escitalopram is sold as the oxalate salt. The salt form makes these otherwise lipophilic compounds watersoluble.

External links

Pharmacological information and treatment study information:

Lunbeck's official websites for citalopram under the trade name Cipramil:

Forest's official websites for citalopram under the trade name Celexa:

Template:ChemicalSources

References

  1. "FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 Oct 2023.
  2. Sindrup SH, Bjerre U, Dejgaard A, Brosen K, Aaes-Jorgensen T, Gram LF. (1992). "The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy". Clinical Pharmacology & Therapeutics. 52 (5): 547–552. PMID 1424428.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  3. Atmaca M, Kuloglu M, Tezcan E, Semercioz A. (2002). "The efficacy of citalopram in the treatment of premature ejaculation: a placebo-controlled study". International Journal of Impotence Research. 14 (6): 502–505. PMID 12494286.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  4. Andersen G., Vestergaard K., Riis JO. (1993). "Citalopram for post-stroke pathological crying". Lancet(British edition). 342 (8875): 837–839. PMID 8104273.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  5. http://www.biopsychiatry.com/citalopram.html
  6. http://www.mentalhealth.com/drug/p30-c04.html#Head_5
  7. Clayton A, Keller A, McGarvey EL. Burden of phase-specific sexual dysfunction with SSRIs. J Affect Disord 2006;91:27-32. PMID 16430968.
  8. http://www.mentalhealth.com/drug/p30-c04.html#Head_12
  9. Celexa.com
Antidepressants (N06A)
Specific reuptake inhibitors and/or receptor modulators
SSRIsTooltip Selective serotonin reuptake inhibitors
SNRIsTooltip Serotonin–norepinephrine reuptake inhibitors
NRIsTooltip Norepinephrine reuptake inhibitors
NDRIsTooltip Norepinephrine–dopamine reuptake inhibitors
NaSSAsTooltip Noradrenergic and specific serotonergic antidepressants
SARIsTooltip Serotonin antagonist and reuptake inhibitors
SMSTooltip Serotonin modulator and stimulators
Others
Tricyclic and tetracyclic antidepressants
TCAsTooltip Tricyclic antidepressants
TeCAsTooltip Tetracyclic antidepressants
Others
Monoamine oxidase inhibitors
Non-selective
MAOATooltip Monoamine oxidase A-selective
MAOBTooltip Monoamine oxidase B-selective
Adjunctive therapies
Miscellaneous
Category: